臻格生物
上海臻格生物技术有限公司（以下简称“臻格生物”）成立于2017年，是一家注册于中国（上海）自由贸易试验区临港新片区的国家级高新技术企业。臻格生物在上海周浦国际医学园区、美国马里兰州设有研发中心，在上海临港生命蓝湾拥有cGMP中试和商业生产基地。
臻格生物的核心业务为大分子生物药CDMO服务、哺乳动物细胞培养基开发及生产等，具体包括：
大分子药物成药性分析
细胞株开发
工艺开发与优化
中试生产
上海臻格生物技术有限公司（以下简称“臻格生物”）成立于2017年，是一家注册于中国（上海）自由贸易试验区临港新片区的国家级高新技术企业。臻格生物在上海周浦国际医学园区、美国马里兰州设有研发中心，在上海临港生命蓝湾拥有cGMP中试和商业生产基地。
臻格生物的核心业务为大分子生物药CDMO服务、哺乳动物细胞培养基开发及生产等，具体包括：
大分子药物成药性分析
细胞株开发
工艺开发与优化
中试生产
Location: China, Shanghai
Employees: 201-500
Total raised: $100M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | Qiming Ven... | qimingvent... |
| 13.04.2023 | Qiming Ven... | qimingvc.c... |
| - | Cowin Capi... | cowincapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.01.2022 | Series C | $100M | Sofina |
Mentions in press and media 5
| Date | Title | Description |
| 12.01.2022 | China’s ZhenGe Biotech secures $100m in Series C round | Chinese contract development and manufacturing organisation (CDMO) major Shanghai ZhenGe Biotechnology has raised $100 million in a Series C round co-led by Goldman Sachs Asset Management and Sofina. With this, ZhenGe has raised an aggregat... |
| 11.01.2022 | Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina | SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management and So... |
| 11.01.2022 | Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina | SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Shanghai ZhenGe Biotech Co., Ltd. ("ZhenGe Biotech" or "the Company") announced the completion of round C financing of US $100 million, led by Goldman Sachs Asset Management and So... |
| 11.01.2022 | Shanghai ZhenGe Biotech Raises USD100M in Series C Funding | Shanghai ZhenGe Biotech, a Shanghai, China-based company focused on providing a macromolecular biological drug CDMO service, raised USD100M in Series C funding. The round was led by Goldman Sachs Asset Management and Sofina with participati... |
| 30.03.2020 | China’s ZhenGe Biotech banks $51m in Series A round | Premium ZhenGe Biotech, a Chinese macromolecular pharmaceutical contract development and manufacturing organisation (CDMO), has secured $51 million in a Series A round of financing led by Shanghai-based healthcare investment firm LYFE Capit... |